VIKING GLOBAL INVESTORS LP 13D/13G Filings for Ginkgo Bioworks Holdings, Inc. (DNA)

VIKING GLOBAL INVESTORS LP 13D and 13G filings for Ginkgo Bioworks Holdings, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-14
10:16 am
Unchanged
2023-12-3113GGinkgo Bioworks Holdings, Inc.
DNA
VIKING GLOBAL INVESTORS LP3,577,128
8.800%
0
(Unchanged)
Filing
2023-02-14
1:18 pm
Purchase
2022-12-3113GGinkgo Bioworks Holdings, Inc.
DNA
VIKING GLOBAL INVESTORS LP3,577,128
9.360%
700,025increase
(+24.33%)
Filing
2022-07-01
5:00 pm
Purchase
2022-06-2813GGinkgo Bioworks Holdings, Inc.
DNA
VIKING GLOBAL INVESTORS LP2,877,103
9.700%
1,600,725increase
(+125.41%)
Filing
2022-03-04
5:21 pm
Sale
2022-03-0213DGinkgo Bioworks Holdings, Inc.
DNA
VIKING GLOBAL INVESTORS LP1,276,379
4.990%
-6,297,196decrease
(-83.15%)
Filing
2021-10-01
5:02 pm
Unchanged
2021-09-2713DGinkgo Bioworks Holdings, Inc.
DNA
VIKING GLOBAL INVESTORS LP7,573,574
22.800%
0
(Unchanged)
Filing
2021-09-27
5:17 pm
Purchase
2021-09-1613DGinkgo Bioworks Holdings, Inc.
DNA
VIKING GLOBAL INVESTORS LP7,573,574
22.800%
7,573,574increase
(New Position)
Filing